Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Butterfleye Study

Randomized, Controlled, Multi-center Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients with Retinopathy of Prematurity

Purpose of Study

To compare afibercept to laser therapy in babies who have Retinopathy of Prematurity (ROP).

Basic Eligibility Criteria

  • Premature infant diagnosed with Retinopathy of Prematurity (ROP)

How to Contact Us

Principal Investigator: Faruk Orge, MD
Study Coordinator: Leslie Richards | 216-844-7934